Nadia Sattar, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 16 years
- Graduated 2010
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Endeavor Health Clinical Operations. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sattar’s office at (408) 445-4010 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A183130 · Current
Licensed to practise in California · since 2022 · expires 2028-11-30 · King Edward Medical University, Lahore.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Geriatric Medicine
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 93.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Northshore University Healthsystem - Evanston HospitalEvanston, ILAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of NorthShore � Edward-Elmhurst Health, which runs 8 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.58 (0.38 to 0.79), Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 127.88 (89.6 to 166.16) · 238 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 4.26 (0 to 8.83) · 2,433 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.45 (0 to 5.18) · 2,425 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.1 (0 to 0.47) · 22,733 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.559, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.109, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.238, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.249, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.3 (2.3 to 4.7) · 751 cases, Jan 2024 – Dec 2024Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 6.9 (5.3 to 8.8) · 751 cases, Jan 2024 – Dec 2024Better than the national rate — Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies): 10.2 (8.6 to 12.1) · 9,680 cases, Jan 2022 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 0.9) · 4,358 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Northshore University Healthsystem - Evanston Hospital
Behind the star rating — Deaths: 7 better, 1 the same, 0 worse of 8 measures. Safety: 5 better, 3 the same, 0 worse of 8 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.58 (0.38 to 0.79) | Better | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 127.88 (89.6 to 166.16) · 238 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.26 (0 to 8.83) · 2,433 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.45 (0 to 5.18) · 2,425 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.1 (0 to 0.47) · 22,733 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.559 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.109 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.238 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.249 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 3.3 (2.3 to 4.7) · 751 cases | Better | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 6.9 (5.3 to 8.8) · 751 cases | Better | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.2 (8.6 to 12.1) · 9,680 cases | Better | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 0.9) · 4,358 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.73 (0 to 1.46) · 4,624 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 73 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 379 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.6 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.1 · 1,690 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11 · 2,359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 649 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 10,221 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.29) · 26,217 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.19 to 0.48) · 26,397 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (2.14 to 4.78) · 6,980 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.75) · 2,420 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.9 (0.83 to 2.97) · 6,622 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.22 (0.86 to 3.58) · 1,393 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 850 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.495 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.889 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 575 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 7 · 573 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 5.3 · 1,906 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.4 · 2,497 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 2,420 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 828 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.8 · 83 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 464 cases | None | Jul 2023 – Jun 2025 |
What patients said (3,985 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$24,542
Medicare paid this office $24,542 for 95 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 67 | $11,018 | $116 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $4,052 | $162 |
| Long return visit (40+ min) | 16 | $2,365 | $139 |
| Short return visit (20+ min) | 23 | $2,021 | $81 |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Removal of impacted ear wax | – | – | – | 15 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
95 Original Medicare patients in 2024. Average age 73 · Women 77% · Also on Medicaid 12% · Health risk score 0.88. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 64% · Diabetes 23% · Chronic kidney disease 19% · Depression 19% · Coronary heart disease 16% · Cancer 13%.
The office billed $66,840, Medicare allowed $31,125 and paid $24,542; for 209 services of 20 kinds; $2,784 of it was for drugs given in the office and $21,758 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 95 | 209 | 73 | 0.88 | $66,840 | $24,542 |
| 2023 | 228 | 336 | 76 | 1.19 | $75,736 | $31,344 |
| 2022 | 293 | 409 | 76 | 1.10 | $73,167 | $35,297 |
| 2021 | 168 | 341 | 71 | 3.00 | $119,406 | $31,866 |
| 2020 | 187 | 545 | 70 | 3.89 | $208,779 | $50,224 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 92 | $12,601 | $137 |
| Return visit (30+ min) | 83 | $6,190 | $66 |
| Long return visit (40+ min) | 34 | $3,534 | $96 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 19 | $3,341 | $176 |
| Long return visit (40+ min) | 11 | $1,918 | $174 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $918 | $66 |
| Short return visit (20+ min) | 14 | $369 | $26 |
| Removal of impacted ear wax | 15 | $259 | $17 |
2022: 8 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 88 | $12,090 | $137 |
| Return visit (30+ min) | 113 | $9,934 | $75 |
| Short return visit (20+ min) | 70 | $3,012 | $42 |
| Long return visit (40+ min) | 20 | $2,208 | $110 |
| New patient visit (60+ min) | 14 | $1,705 | $122 |
| New patient visit (45+ min) | 15 | $1,389 | $93 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $930 | $77 |
| Short return visit | 13 | $240 | $18 |
2021: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $15,109 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,839 | $167 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,257 | $141 |
| Long return visit (40+ min) | 16 | $2,013 | $126 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 21 | $1,835 | $87 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,531 | $61 |
| Return visit (30+ min) | 12 | $890 | $68 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 131 | $36,808 | $89 |
| Hospital discharge day management, more than 30 minutes | 51 | $4,628 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,166 | $174 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,218 | $85 |
Medicaid work
$5,945 in 2021
Medicaid paid $5,945 for 206 billed services this clinician did in 2021, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 178 | $5,338 |
| 1ST HOSP IP/OBS SF/LOW 40 | 13 | $343 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 15 | $264 |
| 2021 | 206 | 3 | 19 | $5,945 |
| 2020 | 218 | 1 | 18 | $5,932 |
See the largest Medicaid services in earlier years
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 218 | $5,932 |
Drugs they prescribed that Part D paid
$21,611
Pharmacies billed $21,611 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
762 generic and fewer than 11 brand-name prescriptions · $21,611 in drug cost · 22 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 85 | $1,058 | $12 |
| Levothyroxine | 49 | $664 | $14 |
| Escitalopram | 39 | $624 | $16 |
| Losartan | 32 | $399 | $12 |
| Pravastatin | 19 | $380 | $20 |
See all 18 drugs
| Atorvastatin | 85 | $1,058 | $12 |
| Levothyroxine | 49 | $664 | $14 |
| Escitalopram | 39 | $624 | $16 |
| Losartan | 32 | $399 | $12 |
| Pravastatin | 19 | $380 | $20 |
| Hydralazine | 17 | $359 | $21 |
| Amlodipine Besylate | 47 | $318 | $7 |
| Omeprazole | 22 | $279 | $13 |
| Rosuvastatin | 25 | $238 | $10 |
| Fluticasone Propionate | 16 | $235 | $15 |
| Donepezil | 11 | $176 | $16 |
| Duloxetine | 14 | $171 | $12 |
| Metoprolol | 11 | $158 | $14 |
| Simvastatin | 19 | $140 | $7 |
| Lisinopril | 14 | $140 | $10 |
| Metformin | 16 | $128 | $8 |
| Hydrochlorothiazide | 13 | $57 | $4 |
| Fluoxetine | 11 | $11 | $1 |
Year by year
| 2024 | 822 | 216 | None | None | $21,611 |
| 2023 | 2,223 | 343 | 2% (48) | 12% | $174,129 |
| 2022 | 981 | 273 | 2% (19) | 10% | $69,105 |
| 2021 | 145 | 70 | 15% (21) | None | $14,361 |
| 2020 | 173 | 49 | 7% (12) | None | $33,023 |
| 2019 | 16 | None | 0% (0) | None | $1,004 |
| 2018 | 30 | 15 | 0% (0) | None | $611 |
| 2017 | 165 | 35 | 0% (0) | 10% | $6,333 |
| 2016 | 452 | 78 | 0% (0) | None | $27,594 |
| 2015 | 82 | 14 | None | None | $4,157 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 51 drugs
| Eliquis | 39 | $36,824 | $944 |
| Ozempic | 18 | $31,440 | $1,747 |
| Lantus Solostar | 20 | $9,376 | $469 |
| Atorvastatin | 235 | $4,325 | $18 |
| Levothyroxine | 120 | $2,333 | $19 |
| Duloxetine | 29 | $2,276 | $78 |
| Losartan | 127 | $1,746 | $14 |
| Lisinopril | 77 | $1,421 | $18 |
| Rosuvastatin | 61 | $1,377 | $23 |
| Escitalopram | 52 | $1,273 | $24 |
| Metoprolol | 61 | $1,152 | $19 |
| Amlodipine Besylate | 96 | $1,045 | $11 |
| Synthroid | 12 | $846 | $71 |
| Fluticasone Propionate | 33 | $785 | $24 |
| Omeprazole | 55 | $752 | $14 |
| Hydrocodone-Acetaminophen | 21 | $596 | $28 |
| Irbesartan | 11 | $577 | $52 |
| Spironolactone | 23 | $564 | $25 |
| Tamsulosin | 31 | $542 | $17 |
| Gabapentin | 17 | $522 | $31 |
| Diclofenac | 13 | $513 | $39 |
| Levetiracetam | 13 | $466 | $36 |
| Pantoprazole | 30 | $434 | $14 |
| Triamterene-Hydrochlorothiazid | 26 | $428 | $16 |
| Metformin Hcl Er | 30 | $409 | $14 |
| Metformin | 48 | $395 | $8 |
| Albuterol Sulfate Hfa | 11 | $368 | $33 |
| Simvastatin | 34 | $350 | $10 |
| Famotidine | 19 | $336 | $18 |
| Chlorthalidone | 11 | $314 | $29 |
| Pravastatin | 19 | $311 | $16 |
| Atenolol | 14 | $292 | $21 |
| Temazepam | 19 | $281 | $15 |
| Baclofen | 14 | $270 | $19 |
| Alprazolam | 21 | $266 | $13 |
| Metoprolol | 28 | $258 | $9 |
| Morphine Sulfate | 11 | $256 | $23 |
| Carvedilol | 19 | $252 | $13 |
| Hydrocortisone | 18 | $231 | $13 |
| Trazodone | 23 | $206 | $9 |
| Hydrochlorothiazide | 39 | $204 | $5 |
| Meloxicam | 11 | $179 | $16 |
| Finasteride | 13 | $177 | $14 |
| Paxlovid (Eua) | 17 | $174 | $10 |
| Alendronate | 18 | $151 | $8 |
| Losartan-Hydrochlorothiazide | 12 | $150 | $13 |
| Sertraline | 27 | $144 | $5 |
| Furosemide | 16 | $113 | $7 |
| Zolpidem | 11 | $111 | $10 |
| Ramipril | 11 | $70 | $6 |
| Lisinopril-Hydrochlorothiazide | 11 | $17 | $2 |
2022: 26 drugs
| Eliquis | 32 | $22,120 | $691 |
| Atorvastatin | 82 | $1,041 | $13 |
| Escitalopram | 28 | $922 | $33 |
| Rosuvastatin | 32 | $922 | $29 |
| Levothyroxine | 37 | $789 | $21 |
| Duloxetine | 32 | $553 | $17 |
| Metoprolol | 41 | $528 | $13 |
| Fluticasone Propionate | 22 | $508 | $23 |
| Losartan | 46 | $488 | $11 |
| Valacyclovir | 15 | $453 | $30 |
| Metformin Hcl Er | 20 | $395 | $20 |
| Diclofenac | 15 | $287 | $19 |
| Hydrocortisone | 11 | $276 | $25 |
| Amlodipine Besylate | 38 | $275 | $7 |
| Omeprazole | 21 | $271 | $13 |
| Lisinopril | 29 | $238 | $8 |
| Pantoprazole | 13 | $199 | $15 |
| Paxlovid (Eua) | 16 | $173 | $11 |
| Alprazolam | 18 | $143 | $8 |
| Gabapentin | 15 | $137 | $9 |
| Simvastatin | 18 | $122 | $7 |
| Hydrochlorothiazide | 20 | $96 | $5 |
| Tramadol | 11 | $93 | $8 |
| Metformin | 14 | $64 | $5 |
| Lorazepam | 11 | $59 | $5 |
| Meloxicam | 13 | $41 | $3 |
2021: 1 drug
| Eliquis | 12 | $5,791 | $483 |
2020: 1 drug
| Eliquis | 12 | $9,558 | $797 |
2017: 2 drugs
| Atorvastatin | 19 | $145 | $8 |
| Metoprolol | 16 | $46 | $3 |
2016: 11 drugs
| Crestor | 11 | $2,739 | $249 |
| Montelukast | 13 | $401 | $31 |
| Atorvastatin | 32 | $262 | $8 |
| Metoprolol | 14 | $108 | $8 |
| Pantoprazole | 16 | $104 | $7 |
| Ramipril | 13 | $104 | $8 |
| Amlodipine Besylate | 18 | $78 | $4 |
| Omeprazole | 12 | $59 | $5 |
| Carvedilol | 12 | $58 | $5 |
| Furosemide | 22 | $57 | $3 |
| Metformin | 11 | $48 | $4 |
Professional record
- NPI
- 1750769121
- Licence
- CA A183130California A183130: Current · expires 2028-11-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- IL 1750769121
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2015-05-18
- NPI last updated
- 2023-09-13
- NPI record certified
- 2023-09-13
This is when the NPI record was last certified, not a medical board exam.